AstraZeneca plc (AZN) Ordinary US$0.25
Share news, reports & tips
21 September 2020 12:48
(Sharecast News) - AstraZeneca disclosed details of its Covid-19 vaccine trials at the weekend to address criticism around pharmaceutical companies' transparency and avoid the risk of engendering...
21 September 2020 08:36
(Sharecast News) - Pharmaceutical giant AstraZeneca issued updates on the status of several drug candidates early on Monday.
17 September 2020 12:50
(Sharecast News) - The Covid19 vaccine being trialled by AstraZeneca and the University of Oxford was likely not behind the symptoms of one participant which led to the pause in the phase three trials last...
16 September 2020 15:24
(Sharecast News) - The US part of the phase three trial of the Covid-19 vaccine candidate being developed by AstraZeneca and the University of Oxford remains on hold, pending authorisation for a restart from...
15 September 2020 23:25
(Sharecast News) - Pfizer's phase three clinical trial for its Covid-19 vaccine candidate has encountered no safety problems even after over 12,000 volunteers had been administered a second dose.
14 September 2020 18:57
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's...
12 September 2020 15:55
(Sharecast News) - The University of Oxford and AstraZeneca will resume trials of their Covid-19 vaccine candidate after receiving clearance from the UK's Medicines Health Regulatory Authority.
10 September 2020 14:37
(Sharecast News) - AstraZeneca's boss said that the Covid-19 vaccine that it was developing together with the University of Oxford could still be ready by the end of 2020.
10 September 2020 09:00
(Sharecast News) - AstraZeneca said on Thursday that its Fasenra asthma drug met both co-primary endpoints in a phase III trial for patients with chronic rhinosinusitis with nasal polyps.
9 September 2020 14:27
(Sharecast News) - Stocks in Europe are moving higher tracking a bounce on Wall Street with investors for the moment shrugging off news that AstraZeneca had paused the phase three clinical trials of its...
9 September 2020 13:25
(Sharecast News) - Analysts at Jefferies reiterated their 'hold' recommendation for shares of AstraZeneca following the pharma giant's decision to press the pause button on its phase three...
9 September 2020 12:52
(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.